Evolution of the Average Target: Indivior Pharmaceuticals, Inc.

Evolution of the Target Price: Indivior Pharmaceuticals, Inc.

Changes in Analyst Recommendations: Indivior Pharmaceuticals, Inc.

4358a94f45ec2d21f2ec63db5.GDmmeL2qmWoEGQxInfxgodpWEoai8uptTSavdb8Z7Qk.cmHjSueSwVJddk8Q0KpZ2Ks9YezvoJpYIBbWP-hWlz5vdMsU0ufPLGB4VQ~d44d82fc6665cd25cc0d34810bbe9dee

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+40.48%
+14.96%
+2.93%
+5.55%
+5.2%
+9.33%
+26.44%
+0.53%
+10.16%
+5.35%
Average +12.09%
Weighted average by Cap. +9.49%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
34.88USD
Average target price
49.00USD
Spread / Average Target
+40.48%
High Price Target
53.00USD
Spread / Highest target
+51.95%
Low Price Target
43.00USD
Spread / Lowest Target
+23.28%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. INDV Stock
  4. Consensus Indivior Pharmaceuticals, Inc.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!